News/ News/ R&D/ Top stories UCB sets sights on rare diseases giant Alexion with Ra Pharma acquisition Richard Staines Alexion, Ra Pharma, Rare diseases, UCB 0 Comment UCB is to buy US biotech Ra Pharma in a deal worth around $2.1 billion, adding a late-stage Share X UCB sets sights on rare diseases giant Alexion with Ra Pharma acquisition https://pharmaphorum.com/news/ucb-takes-on-rare-diseases-giant-alexion-with-ra-pharma-acquisition/
